114 related articles for article (PubMed ID: 30124440)
1. Ductal carcinoma in-situ, cystic hypersecretory type presented by recurrent hemorrhagic cyst.
Denariyakoon S; Watcharakul C; Techanitisawat P; Chulakadabba A; Sampatanukul P; Boonjunwetwat D; Chatamra K
Breast Dis; 2018; 37(4):225-227. PubMed ID: 30124440
[TBL] [Abstract][Full Text] [Related]
2. Invasive cystic hypersecretory carcinoma of the breast: a rare variant of breast cancer: a case report and review of the literature.
Sun J; Wang X; Wang C
BMC Cancer; 2019 Jan; 19(1):31. PubMed ID: 30621638
[TBL] [Abstract][Full Text] [Related]
3. Cystic hypersecretory ductal carcinoma of the breast: a rare cause of cystic breast mass.
Song SW; Whang IY; Chang ED
Jpn J Radiol; 2011 Nov; 29(9):660-2. PubMed ID: 21956373
[TBL] [Abstract][Full Text] [Related]
4. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
Huo L; Sneige N; Hunt KK; Albarracin CT; Lopez A; Resetkova E
Cancer; 2006 Oct; 107(8):1760-8. PubMed ID: 16977650
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathologic features of cystic hypersecretory lesion of the breast].
Bi R; Cheng Y; Yu B; Shui R; Yang W; Xu X
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):25-9. PubMed ID: 24713245
[TBL] [Abstract][Full Text] [Related]
6. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
Piubello Q; Montemezzi S; D'Atri C
Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
[TBL] [Abstract][Full Text] [Related]
7. Recognizing breast ductal carcinoma in situ on fine-needle aspiration: a diagnostic dilemma.
Guo HQ; Zhang ZH; Zhao H; Zhao LL; Pan QJ
Diagn Cytopathol; 2013 Aug; 41(8):710-5. PubMed ID: 23729369
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy.
Deshaies I; Provencher L; Jacob S; Côté G; Robert J; Desbiens C; Poirier B; Hogue JC; Vachon E; Diorio C
Breast; 2011 Feb; 20(1):50-5. PubMed ID: 20619647
[TBL] [Abstract][Full Text] [Related]
9. Regressive change in high-grade ductal carcinoma in situ of the breast: histopathologic spectrum and biologic importance.
Wasserman JK; Parra-Herran C
Am J Clin Pathol; 2015 Sep; 144(3):503-10. PubMed ID: 26276781
[TBL] [Abstract][Full Text] [Related]
10. Sonographic findings in a patient with cystic hypersecretory duct carcinoma of the breast.
Park C; Jung JI; Lee AW; Cheon HM; Hahn ST; Lee JM
J Clin Ultrasound; 2004 Jan; 32(1):29-32. PubMed ID: 14705175
[TBL] [Abstract][Full Text] [Related]
11. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
Renshaw AA; Derhagopian RP; Martinez P; Gould EW
Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
[TBL] [Abstract][Full Text] [Related]
12. Reflex Estrogen Receptor (ER) and Progesterone Receptor (PR) Analysis of Ductal Carcinoma In Situ (DCIS) in Breast Needle Core Biopsy Specimens: An Unnecessary Exercise That Costs the United States $35 Million/y.
VandenBussche CJ; Cimino-Mathews A; Park BH; Emens LA; Tsangaris TN; Argani P
Am J Surg Pathol; 2016 Aug; 40(8):1090-9. PubMed ID: 27299796
[TBL] [Abstract][Full Text] [Related]
13. The outcome of papillary lesions of the breast diagnosed by standard core needle biopsy within a BreastScreen Australia service.
Armes JE; Galbraith C; Gray J; Taylor K
Pathology; 2017 Apr; 49(3):267-270. PubMed ID: 28238415
[TBL] [Abstract][Full Text] [Related]
14. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
15. Ductal carcinoma in situ diagnosed by breast needle biopsy: Predictors of invasion in the excision specimen.
Doebar SC; de Monyé C; Stoop H; Rothbarth J; Willemsen SP; van Deurzen CH
Breast; 2016 Jun; 27():15-21. PubMed ID: 27212695
[TBL] [Abstract][Full Text] [Related]
16. Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ.
Grimm LJ; Ghate SV; Hwang ES; Soo MS
Acad Radiol; 2017 Nov; 24(11):1364-1371. PubMed ID: 28705686
[TBL] [Abstract][Full Text] [Related]
17. The significance of extracellular mucin in breast fine needle aspiration specimens.
Shield PW; Ribu DL; Cominos D
Cytopathology; 2016 Jun; 27(3):185-92. PubMed ID: 26104545
[TBL] [Abstract][Full Text] [Related]
18. [In situ ductal carcinoma of the breast: a diagnostic challenge].
Fuchsjäger MH; Helbich TH
Wien Med Wochenschr Suppl; 2002; (113):69-73. PubMed ID: 12621847
[TBL] [Abstract][Full Text] [Related]
19. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
20. Intracystic papillary carcinoma associated with ductal carcinoma in situ in a male breast.
Dragoumis DM; Tsiftsoglou AP
J Postgrad Med; 2008; 54(1):39-40. PubMed ID: 18296806
[No Abstract] [Full Text] [Related]
[Next] [New Search]
